|
Real-time Estimate
Cboe BZX
18:38:04 14/01/2026 +04
|
5-day change
|
1st Jan Change
|
|
480.50 USD
|
+0.76%
|
 |
-5.14%
|
-2.13%
|
|
01-07 |
SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026
|
CI
| |
01-06 |
United Therapeutics Insider Sold Shares Worth $500,015, According to a Recent SEC Filing
|
MT
| |
12-30 |
United Therapeutics Insider Sold Shares Worth $11,572,963, According to a Recent SEC Filing
|
MT
| |
12-30 |
United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing
|
MT
| |
12-24 |
United Therapeutics Insider Sold Shares Worth $3,047,201, According to a Recent SEC Filing
|
MT
| |
12-17 |
United Therapeutics Insider Sold Shares Worth $3,952,689, According to a Recent SEC Filing
|
MT
| |
12-17 |
United Therapeutics Insider Sold Shares Worth $1,742,193, According to a Recent SEC Filing
|
MT
| |
12-17 |
United Therapeutics Insider Sold Shares Worth $11,166,722, According to a Recent SEC Filing
|
MT
| |
12-11 |
United Therapeutics Insider Sold Shares Worth $3,833,374, According to a Recent SEC Filing
|
MT
| |
12-10 |
United Therapeutics Insider Sold Shares Worth $10,050,597, According to a Recent SEC Filing
|
MT
| |
12-09 |
United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing
|
MT
| |
12-06 |
United Therapeutics Insider Sold Shares Worth $3,821,130, According to a Recent SEC Filing
|
MT
| |
12-03 |
United Therapeutics Insider Sold Shares Worth $10,798,079, According to a Recent SEC Filing
|
MT
| |
12-03 |
United Therapeutics Insider Sold Shares Worth $3,852,846, According to a Recent SEC Filing
|
MT
| |
12-03 |
United Therapeutics Insider Sold Shares Worth $10,079,696, According to a Recent SEC Filing
|
MT
| |
11-26 |
United Therapeutics Insider Sold Shares Worth $3,784,419, According to a Recent SEC Filing
|
MT
| |
11-22 |
United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing
|
MT
| |
11-21 |
United Therapeutics Insider Sold Shares Worth $3,789,373, According to a Recent SEC Filing
|
MT
| |
11-14 |
United Therapeutics Insider Sold Shares Worth $4,755,854, According to a Recent SEC Filing
|
MT
| |
11-14 |
United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing
|
MT
| |
11-13 |
United Therapeutics Insider Sold Shares Worth $3,600,830, According to a Recent SEC Filing
|
MT
| |
11-07 |
United Therapeutics Insider Sold Shares Worth $3,488,423, According to a Recent SEC Filing
|
MT
| |
11-06 |
United Therapeutics Insider Sold Shares Worth $9,157,821, According to a Recent SEC Filing
|
MT
| |
11-05 |
United Therapeutics Insider Sold Shares Worth $9,658,073, According to a Recent SEC Filing
|
MT
| |
11-05 |
United Therapeutics Insider Sold Shares Worth $3,554,592, According to a Recent SEC Filing
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
